BA

The Boeing Company

57
Fundamentals73/ 100
Valuation50/ 100
Upside potential57/ 100
Risk potential20/ 100

BA offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.

MAS

Masco Corporation

62
Fundamentals63/ 100
Valuation45/ 100
Upside potential58/ 100
Risk potential16/ 100

MAS has the edge over BA overall, supported by lower modeled downside and stronger modeled upside.

BA Fundamentals

MetricStatus
Stable
Healthy
Stable
Under pressure

BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.

MAS Fundamentals

MetricStatus
Stable
Healthy
Strong
Healthy

MAS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.

BA PE Valuation

CHEAPFAIREXPENSIVE25x51x76x102x
CHEAPFAIREXPENSIVE25x51x76x102x
LevelPEPriceVs current
Current18x$172—
Cheap51x$496+189%
Fair82x$790+360%
Expensive91x$876+411%

Historical ranges are pointers, not guarantees.

BA has the edge over MAS in the historical PE scenario, which offers more potential upside but is not a forecast.

MAS PE Valuation

CHEAPFAIREXPENSIVE10x20x30x40x
CHEAPFAIREXPENSIVE10x20x30x40x
LevelPEPriceVs current
Cheap13x$59.97-29%
Fair17x$79.10-6.4%
Current18x$84.48—
Forward18x$84.48—
Expensive21x$97.54+15%

Historical ranges are pointers, not guarantees.

MAS's PE is in its fair range at 18.3x. On analysts' estimates for next year's earnings, today's price would be 18.5x.

BA Forward outlook

MetricOutlook
--
Returning to profit
Growth
Improving
Limited
Low

BA has the edge over MAS on the outlook, with more favorable revenue expectations.

MAS Forward outlook

MetricOutlook
Stable
Growth
Stable
Improving
Limited
Moderate

Analysts expect MAS's earnings to grow and its profitability to improve, with its revenue holding steady.

BA Risk to reward

ScenarioChangePrice
Upside+26%$216.09
Downside-20%$137.47

Calculated from the latest close: $171.55 on Nov 12.

BA trails MAS on modeled risk to reward, with less potential upside relative to its potential downside.

MAS Risk to reward

ScenarioChangePrice
Upside+23%$103.61
Downside-16%$70.86

Calculated from the latest close: $84.48 on Nov 12.

MAS has a better modeled risk to reward balance than BA, with more potential upside relative to its potential downside.

BA Earnings Per Share

Q4 2023: $-3.67Q1 2024: $-3.54Q2 2024: $-5.62Q3 2024: $-12.89Q4 2024: $-18.36Q1 2025: $-17.96Q2 2025: $-16.55Q3 2025: $-13.72Q4 2025: $2.48Q1 2026: $2.53Q2 2026: $2.78Q3 2026: $9.66
Q4 2023: $-3.67Q1 2024: $-3.54Q2 2024: $-5.62Q3 2024: $-12.89Q4 2024: $-18.36Q1 2025: $-17.96Q2 2025: $-16.55Q3 2025: $-13.72Q4 2025: $2.48Q1 2026: $2.53Q2 2026: $2.78Q3 2026: $9.66
QuarterTTM EPSYoY
Q3 2026$9.66+$23.38
Q2 2026$2.78+$19.33
Q1 2026$2.53+$20.49
Q4 2025$2.48+$20.84
Q3 2025-$13.72-$0.83
Q2 2025-$16.55-$10.93
Q1 2025-$17.96-$14.42
Q4 2024-$18.36-$14.69

BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.

MAS Earnings Per Share

Q4 2023: $4.02Q1 2024: $4.09Q2 2024: $4.10Q3 2024: $3.77Q4 2024: $3.76Q1 2025: $3.66Q2 2025: $3.77Q3 2025: $3.90Q4 2025: $3.86Q1 2026: $4.04Q2 2026: $4.36Q3 2026: $4.63Forward: $4.58
Q4 2023: $4.02Q1 2024: $4.09Q2 2024: $4.10Q3 2024: $3.77Q4 2024: $3.76Q1 2025: $3.66Q2 2025: $3.77Q3 2025: $3.90Q4 2025: $3.86Q1 2026: $4.04Q2 2026: $4.36Q3 2026: $4.63Forward: $4.58
QuarterTTM EPSYoY
Forward$4.58-1.1%
Q3 2026$4.63+19%
Q2 2026$4.36+16%
Q1 2026$4.04+10%
Q4 2025$3.86+2.7%
Q3 2025$3.90+3.4%
Q2 2025$3.77-8%
Q1 2025$3.66-11%
Q4 2024$3.76-6.5%

MAS has the edge over BA on earnings, with more consistent year-over-year improvement.

BA Quarterly Revenue

Q4 2023: $22BQ1 2024: $16.6BQ2 2024: $16.9BQ3 2024: $17.8BQ4 2024: $15.2BQ1 2025: $19.5BQ2 2025: $22.7BQ3 2025: $23.3BQ4 2025: $23.9BQ1 2026: $22.2BQ2 2026: $24.6BQ3 2026: $24.2B
Q4 2023: $22BQ1 2024: $16.6BQ2 2024: $16.9BQ3 2024: $17.8BQ4 2024: $15.2BQ1 2025: $19.5BQ2 2025: $22.7BQ3 2025: $23.3BQ4 2025: $23.9BQ1 2026: $22.2BQ2 2026: $24.6BQ3 2026: $24.2B
QuarterRevenueYoY
Q3 2026$24.2B+3.9%
Q2 2026$24.6B+8%
Q1 2026$22.2B+14%
Q4 2025$23.9B+57%
Q3 2025$23.3B+30%
Q2 2025$22.7B+35%
Q1 2025$19.5B+18%
Q4 2024$15.2B-31%

BA has the edge over MAS on sales, with more consistent year-over-year improvement.

MAS Quarterly Revenue

Q4 2023: $1.9BQ1 2024: $1.9BQ2 2024: $2.1BQ3 2024: $2BQ4 2024: $1.8BQ1 2025: $1.8BQ2 2025: $2.1BQ3 2025: $1.9BQ4 2025: $1.8BQ1 2026: $1.9BQ2 2026: $2BQ3 2026: $2B
Q4 2023: $1.9BQ1 2024: $1.9BQ2 2024: $2.1BQ3 2024: $2BQ4 2024: $1.8BQ1 2025: $1.8BQ2 2025: $2.1BQ3 2025: $1.9BQ4 2025: $1.8BQ1 2026: $1.9BQ2 2026: $2BQ3 2026: $2B
QuarterRevenueYoY
Q3 2026$2B+2.6%
Q2 2026$2B-2.9%
Q1 2026$1.9B+6.5%
Q4 2025$1.8B-1.9%
Q3 2025$1.9B-3.3%
Q2 2025$2.1B-1.9%
Q1 2025$1.8B-6.5%
Q4 2024$1.8B-2.9%

MAS's revenue fell from its 2022 peak and has held roughly level since: $2B last quarter, up 2.6% from the same quarter a year ago.

BA Free Cash Flow

Q4 2023: $3BQ1 2024: −$3.9BQ2 2024: −$4.3BQ3 2024: −$2BQ4 2024: −$4.1BQ1 2025: −$2.3BQ2 2025: −$200MQ3 2025: $238MQ4 2025: $375MQ1 2026: −$1.5BQ2 2026: $631MQ3 2026: $464M
Q4 2023: $3BQ1 2024: −$3.9BQ2 2024: −$4.3BQ3 2024: −$2BQ4 2024: −$4.1BQ1 2025: −$2.3BQ2 2025: −$200MQ3 2025: $238MQ4 2025: $375MQ1 2026: −$1.5BQ2 2026: $631MQ3 2026: $464M
QuarterFree cash flowYoY
Q3 2026$464M+95%
Q2 2026$631M+$831M
Q1 2026-$1.5B+$836M
Q4 2025$375M+$4.5B
Q3 2025$238M+$2.2B
Q2 2025-$200M+$4.1B
Q1 2025-$2.3B+$1.6B
Q4 2024-$4.1B-239%

BA has the edge over MAS on cash flow, with more consistent year-over-year improvement.

MAS Free Cash Flow

Q4 2023: $423MQ1 2024: −$125MQ2 2024: $303MQ3 2024: $378MQ4 2024: $351MQ1 2025: −$190MQ2 2025: $270MQ3 2025: $415MQ4 2025: $371MQ1 2026: −$113MQ2 2026: $453MQ3 2026: $332M
Q4 2023: $423MQ1 2024: −$125MQ2 2024: $303MQ3 2024: $378MQ4 2024: $351MQ1 2025: −$190MQ2 2025: $270MQ3 2025: $415MQ4 2025: $371MQ1 2026: −$113MQ2 2026: $453MQ3 2026: $332M
QuarterFree cash flowYoY
Q3 2026$332M-20%
Q2 2026$453M+68%
Q1 2026-$113M+$77M
Q4 2025$371M+5.7%
Q3 2025$415M+9.8%
Q2 2025$270M-11%
Q1 2025-$190M-$65M
Q4 2024$351M-17%

MAS generated $1B in free cash flow over the past year, up 23% from the year before.

BA Total Shares

Q4 2023: 606MQ1 2024: 613MQ2 2024: 616MQ3 2024: 619MQ4 2024: 647MQ1 2025: 753MQ2 2025: 757MQ3 2025: 760MQ4 2025: 762MQ1 2026: 788MQ2 2026: 791MQ3 2026: 793M
Q4 2023: 606MQ1 2024: 613MQ2 2024: 616MQ3 2024: 619MQ4 2024: 647MQ1 2025: 753MQ2 2025: 757MQ3 2025: 760MQ4 2025: 762MQ1 2026: 788MQ2 2026: 791MQ3 2026: 793M
PeriodChange %Net change
Quarterly+0.3%+2.1M shares
1 year+4.3%+32.8M shares
3 years+31%+186M shares
5 years+35%+204M shares
Available history+40%+227M shares

BA has 793M diluted shares, up 4.3% from a year ago.

MAS Total Shares

Q4 2023: 226MQ1 2024: 221MQ2 2024: 220MQ3 2024: 218MQ4 2024: 219MQ1 2025: 213MQ2 2025: 211MQ3 2025: 209MQ4 2025: 210MQ1 2026: 204MQ2 2026: 199MQ3 2026: 196M
Q4 2023: 226MQ1 2024: 221MQ2 2024: 220MQ3 2024: 218MQ4 2024: 219MQ1 2025: 213MQ2 2025: 211MQ3 2025: 209MQ4 2025: 210MQ1 2026: 204MQ2 2026: 199MQ3 2026: 196M
PeriodChange %Net change
Quarterly-1.5%-3M shares
1 year-6.2%-13M shares
3 years-13%-30M shares
5 years-21%-51M shares
Available history-32%-92M shares

MAS has the edge over BA on shareholder dilution, with a more favorable share count trend.

BA Net Leverage

Q4 2023: 36.4xQ1 2024: 36.1xQ2 2024: 361.8xQ4 2025: 6.9xQ1 2026: 6.0xQ2 2026: 5.7xQ3 2026: 3.0x
Q4 2023: 36.4xQ1 2024: 36.1xQ2 2024: 361.8xQ4 2025: 6.9xQ1 2026: 6.0xQ2 2026: 5.7xQ3 2026: 3.0x
QuarterNet LeverageStatus
Q3 20263.0xElevated
Q2 20265.7xHigh
Q1 20266.0xHigh
Q4 20256.9xHigh
Q2 2024361.8xHigh
Q1 202436.1xHigh
Q4 202336.4xHigh
Q3 202396.1xHigh

BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.

MAS Net Leverage

Q4 2023: 1.5xQ1 2024: 1.7xQ2 2024: 1.7xQ3 2024: 1.6xQ4 2024: 1.5xQ1 2025: 1.7xQ2 2025: 1.7xQ3 2025: 1.7xQ4 2025: 1.7xQ1 2026: 1.8xQ2 2026: 1.8xQ3 2026: 1.7x
Q4 2023: 1.5xQ1 2024: 1.7xQ2 2024: 1.7xQ3 2024: 1.6xQ4 2024: 1.5xQ1 2025: 1.7xQ2 2025: 1.7xQ3 2025: 1.7xQ4 2025: 1.7xQ1 2026: 1.8xQ2 2026: 1.8xQ3 2026: 1.7x
QuarterNet LeverageStatus
Q3 20261.7xHealthy
Q2 20261.8xHealthy
Q1 20261.8xHealthy
Q4 20251.7xHealthy
Q3 20251.7xHealthy
Q2 20251.7xHealthy
Q1 20251.7xHealthy
Q4 20241.5xHealthy

MAS has the edge over BA on leverage, with a lower net debt burden relative to earnings.

BA Weekly Momentum

MetricValueStatus
RSI31.1Neutral
Stochastic9.6Oversold

BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).

MAS Weekly Momentum

MetricValueStatus
RSI66.2Neutral
Stochastic80.3Overbought

MAS's weekly RSI is 66 (neutral) and its Stochastic is 80 (overbought).

BA PE vs Industrials Sector

MetricBASector medianRelative
PE18x24x26% below
PE %05858 pts below

BA has the edge over MAS on valuation relative to its sector.

MAS PE vs Industrials Sector

MetricMASSector medianRelative
PE18x24x24% below
PE %59581 pt above

MAS is trading at 18x earnings, a 24% discount to the Industrials sector's median of 24x.

BA Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$184.67.1% below
20 week MA$203.816% below
50 week MA$215.520% below
100 week MA$205.917% below
200 week MA$200.614% below

BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.

MAS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$75.312% above
20 week MA$75.013% above
50 week MA$70.819% above
100 week MA$69.821% above
200 week MA$67.425% above

MAS has the edge over BA on trend strength, trading above more of its moving averages.

BA Yearly ROI

YearStart priceEnd priceROI
2020$330.1$217.2-34%
2021$217.2$204.2-6%
2022$204.2$189.1-7.4%
2023$189.1$260.7+38%
2024$260.7$180.7-31%
2025$180.7$216.4+20%
2026 YTD$216.4$171.6-21%

BA has finished lower in four of the last six years. It's down 21% so far in 2026.

MAS Yearly ROI

YearStart priceEnd priceROI
2020$48.1$56.8+18%
2021$56.8$68.0+20%
2022$68.0$47.1-31%
2023$47.1$67.0+42%
2024$67.0$73.2+9.3%
2025$73.2$64.7-12%
2026 YTD$64.7$84.5+30%

MAS has the edge over BA on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key